Trial Profile

A registrational study of LX2006

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 18 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Oct 2025 According to Lexeo media release, company plans to initiate the LX2006 pivotal study as soon as possible in the first half of 2026, pending finalization of the trial protocol. Company believes regulatory feedback received for phase 1/2 studies, has the potential to reduce the size and length of the planned pivotal study, possibly accelerating the overall timeline to BLA submission.
14 Aug 2025 According to Lexeo media release, the company expects final alignment with FDA on the LX2006 registrational study in late Q3 to early Q4 2025.
19 May 2025 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com